Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1975 1
1977 1
1980 1
1981 1
1982 1
1983 1
1984 4
1985 5
1986 3
1987 5
1988 3
1989 6
1990 7
1991 8
1992 7
1993 4
1994 5
1995 1
1996 5
1997 3
1998 5
1999 10
2000 7
2001 5
2002 10
2003 8
2004 2
2005 5
2006 7
2007 8
2008 10
2009 9
2010 12
2011 12
2012 15
2013 8
2014 10
2015 15
2016 12
2017 12
2018 13
2019 13
2020 13
2021 5
2022 8
2023 5
2024 10
2025 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

304 results

Results by year

Filters applied: . Clear all
Page 1
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies.
Benjamin R, Graham C, Yallop D, Jozwik A, Mirci-Danicar OC, Lucchini G, Pinner D, Jain N, Kantarjian H, Boissel N, Maus MV, Frigault MJ, Baruchel A, Mohty M, Gianella-Borradori A, Binlich F, Balandraud S, Vitry F, Thomas E, Philippe A, Fouliard S, Dupouy S, Marchiq I, Almena-Carrasco M, Ferry N, Arnould S, Konto C, Veys P, Qasim W; UCART19 Group. Benjamin R, et al. Lancet. 2020 Dec 12;396(10266):1885-1894. doi: 10.1016/S0140-6736(20)32334-5. Lancet. 2020. PMID: 33308471 Free PMC article. Clinical Trial.
UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial.
Benjamin R, Jain N, Maus MV, Boissel N, Graham C, Jozwik A, Yallop D, Konopleva M, Frigault MJ, Teshima T, Kato K, Boucaud F, Balandraud S, Gianella-Borradori A, Binlich F, Marchiq I, Dupouy S, Almena-Carrasco M, Pannaux M, Fouliard S, Brissot E, Mohty M; CALM Study Group. Benjamin R, et al. Lancet Haematol. 2022 Nov;9(11):e833-e843. doi: 10.1016/S2352-3026(22)00245-9. Epub 2022 Oct 10. Lancet Haematol. 2022. PMID: 36228643 Free PMC article. Clinical Trial.
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial.
Frigault MJ, Dietrich J, Gallagher K, Roschewski M, Jordan JT, Forst D, Plotkin SR, Cook D, Casey KS, Lindell KA, Depinho GD, Katsis K, Elder EL, Leick MB, Choi B, Horick N, Preffer F, Saylor M, McAfee S, O'Donnell PV, Spitzer TR, Dey B, DeFilipp Z, El-Jawahri A, Batchelor TT, Maus MV, Chen YB. Frigault MJ, et al. Among authors: spitzer tr. Blood. 2022 Apr 14;139(15):2306-2315. doi: 10.1182/blood.2021014738. Blood. 2022. PMID: 35167655 Free PMC article. Clinical Trial.
[Subglottic carcinoma].
Bahar G, Nageris BI, Spitzer T, Popovtzer A, Mharshak G, Feinmesser R. Bahar G, et al. Among authors: spitzer t. Harefuah. 2002 Oct;141(10):914-8, 929. Harefuah. 2002. PMID: 12420600 Review. Hebrew.
Multiple myeloma.
Spitzer TR, Sachs DH, Cosimi B. Spitzer TR, et al. N Engl J Med. 2011 Jun 16;364(24):2364; author reply 2364. doi: 10.1056/NEJMc1104560. N Engl J Med. 2011. PMID: 21675904 No abstract available.
Cytokines in transplantation tolerance.
Souffrant A, Wilson A, Hansen B, Tomofuji K, Otsuka R, Benichou G, Spitzer T, Kawai T. Souffrant A, et al. Among authors: spitzer t. Best Pract Res Clin Haematol. 2025 Jun;38(2):101627. doi: 10.1016/j.beha.2025.101627. Epub 2025 May 24. Best Pract Res Clin Haematol. 2025. PMID: 40701741 Review.
Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT.
DeFilipp Z, Kim HT, Knight LW, O'Connor SM, Dhaver SE, White M, Dholaria B, Schroeder MA, Vasu S, Abedin S, Chung J, El-Jawahri A, Frigault MJ, McAfee S, Newcomb RA, O'Donnell PV, Spitzer TR, Chen YB, Hobbs GS. DeFilipp Z, et al. Among authors: spitzer tr. Blood. 2025 May 15;145(20):2312-2316. doi: 10.1182/blood.2024028005. Blood. 2025. PMID: 40106768 Clinical Trial.
Biomarkers of Stress and Male Fertility.
Spitzer TL, Trussell JC, Coward RM, Hansen KR, Barnhart KT, Cedars MI, Diamond MP, Krawetz SA, Sun F, Zhang H, Santoro N, Steiner AZ. Spitzer TL, et al. Reprod Sci. 2022 Apr;29(4):1262-1270. doi: 10.1007/s43032-022-00853-x. Epub 2022 Feb 1. Reprod Sci. 2022. PMID: 35106743 Free PMC article.
Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract.
DeFilipp Z, Damania AV, Kim HT, Chang CC, El-Jawahri A, McAfee SL, Bottoms AS, Toncheva V, Smith MM, Dolaher M, Perry L, White M, Diana B, Connolly S, Dey BR, Frigault MJ, Newcomb RA, O'Donnell PV, Spitzer TR, Mansour MK, Weber D, Ajami NJ, Hohmann E, Jenq RR, Chen YB. DeFilipp Z, et al. Among authors: spitzer tr. Blood Adv. 2024 May 14;8(9):2074-2084. doi: 10.1182/bloodadvances.2024012556. Blood Adv. 2024. PMID: 38471063 Free PMC article. Clinical Trial.
304 results